Literature DB >> 2463241

Establishment of two cell lines from hamster buccal pouch tumors induced by topical 7,12-dimethylbenz(a)anthracene and topical DMBA in conjunction with herpes simplex virus infection.

N H Park1, S D Hudnall, D I Paik, A D Stock.   

Abstract

Two cell lines designated HBPC-1 and HBPC-2 have been established from hamster buccal pouch tumors induced by topical 7,12-dimethylbenz(a)anthracene (DMBA) and DMBA in conjunction with type 1 herpes simplex virus infection, respectively. The cells are epithelial in morphology, have a doubling time of approximately 18 h, and require bovine serum for optimal growth. The karyotype is aneuploid, with several marker chromosomes, and the cells produce squamous cell carcinomas when transplanted into normal hamster pouch tissues.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2463241     DOI： 10.1007/bf02624186

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN： 0883-8364


  15 in total

1.  Experimental carcinogenesis in the cheek pouch of the Syrian hamster.

Authors:  J J SALLEY
Journal:  J Dent Res       Date:  1954-04       Impact factor: 6.116

2.  Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation.

Authors:  J L Li; M A Jerkofsky; F Rapp
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

3.  In vitro cultivation of a chemically induced epidermal carcinoma: establishment of three cell lines and isolation of murine leukemia virus.

Authors:  S H Yuspa; D L Morgan; J A Levy
Journal:  J Natl Cancer Inst       Date:  1973-06       Impact factor: 13.506

4.  Rapid induction of gamma-glutamyl transpeptidase-rich intraepithelial clones in 7,12-dimethylbenz(a)anthracene-treated hamster buccal pouch.

Authors:  D B Solt; G Shklar
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

5.  An epidermoid carcinoma cell line derived from hamster 7,12-dimethylbenz[a]anthracene-induced buccal pouch tumors.

Authors:  O Odukoya; J Schwartz; R Weichselbaum; G Shklar
Journal:  J Natl Cancer Inst       Date:  1983-12       Impact factor: 13.506

6.  Neutralizing antibody to herpes simplex virus type 1 in patients with oral cancer.

Authors:  E J Shillitoe; D Greenspan; J S Greenspan; L S Hansen; S Silverman
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

7.  Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

8.  Herpes virus inactivation by chemical carcinogens: differential inactivation of herpes simplex viruses by 4-nitroquinoline 1-oxide and related compounds.

Authors:  D Speelman; J L Li; V M Ramanujam; M S Legator; T Albrecht
Journal:  Environ Mutagen       Date:  1981

9.  Induction of uterine cancer with inactivated herpes simplex virus, types 1 and 2.

Authors:  W B Wentz; J W Reagan; A D Heggie; Y S Fu; D D Anthony
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

10.  Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulva.

Authors:  R H Kaufman; G R Dreesman; J Burek; M O Korhonen; D O Matson; J L Melnick; K L Powell; D J Purifoy; R J Courtney; E Adam
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.